Literature DB >> 25600973

Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.

Lisa E Cole1, Ryan D Ross, Jennifer Mr Tilley, Tracy Vargo-Gogola, Ryan K Roeder.   

Abstract

Computed tomography enables 3D anatomic imaging at a high spatial resolution, but requires delivery of an x-ray contrast agent to distinguish tissues with similar or low x-ray attenuation. Gold nanoparticles (AuNPs) have gained recent attention as an x-ray contrast agent due to exhibiting a high x-ray attenuation, nontoxicity and facile synthesis and surface functionalization for colloidal stability and targeted delivery. Potential diagnostic applications include blood pool imaging, passive targeting and active targeting, where actively targeted AuNPs could enable molecular imaging by computed tomography. This article summarizes the current state of knowledge for AuNP x-ray contrast agents within a paradigm of key structure-property-function relationships in order to provide guidance for the design of AuNP contrast agents to meet the necessary functional requirements in a particular application. Functional requirements include delivery to the site of interest (e.g., blood, tumors or microcalcifications), nontoxicity during delivery and clearance, targeting or localization at the site of interest and contrast enhancement for the site of interest compared with surrounding tissues. Design is achieved by strategically controlling structural characteristics (composition, mass concentration, size, shape and surface functionalization) for optimized properties and functional performance. Examples from the literature are used to highlight current design trade-offs that exist between the different functional requirements.

Entities:  

Keywords:  computed tomography; contrast agent; delivery; gold nanoparticles; surface functionalization; targeting; x-ray imaging

Mesh:

Substances:

Year:  2015        PMID: 25600973     DOI: 10.2217/nnm.14.171

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  63 in total

1.  In vivo performance of gold nanoparticle-loaded absorbable inferior vena cava filters in a swine model.

Authors:  Steven Y Huang; Jossana A Damasco; Li Tian; Linfeng Lu; Joy Vanessa D Perez; Katherine A Dixon; Malea L Williams; Megan C Jacobsen; Stephen J Dria; Mitchell D Eggers; Adam D Melancon; Rick R Layman; Elizabeth M Whitley; Marites P Melancon
Journal:  Biomater Sci       Date:  2020-06-19       Impact factor: 6.843

2.  Quantification of multiple mixed contrast and tissue compositions using photon-counting spectral computed tomography.

Authors:  Tyler E Curtis; Ryan K Roeder
Journal:  J Med Imaging (Bellingham)       Date:  2019-02-11

Review 3.  Nanotechnology and its use in imaging and drug delivery (Review).

Authors:  Serjay Sim; Nyet Kui Wong
Journal:  Biomed Rep       Date:  2021-03-05

Review 4.  Current Status and Future Direction of Nanomedicine: Focus on Advanced Biological and Medical Applications.

Authors:  Eun-Mi Kim; Hwan-Jeong Jeong
Journal:  Nucl Med Mol Imaging       Date:  2016-08-09

Review 5.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

6.  Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography.

Authors:  Pratap C Naha; Kristen C Lau; Jessica C Hsu; Maryam Hajfathalian; Shaameen Mian; Peter Chhour; Lahari Uppuluri; Elizabeth S McDonald; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2016-07-14       Impact factor: 7.790

Review 7.  Nanoparticle contrast agents for X-ray imaging applications.

Authors:  Jessica C Hsu; Lenitza M Nieves; Oshra Betzer; Tamar Sadan; Peter B Noël; Rachela Popovtzer; David P Cormode
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-22

8.  Characterization and comparison of imaging contrast enhancement with PEG-functionalized gold nanoparticles in kV cone beam computed tomography and computed tomography imaging.

Authors:  Tara Gray; Nema Bassiri; Shaquan David; Devanshi Yogeshkumar Patel; Mohammad Abdul-Moqueet; Neil Kirby; Kathryn M Mayer
Journal:  Biomed Phys Eng Express       Date:  2020-05-29

Review 9.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

Review 10.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.